Como entrar em contato com o centro
Centro de saúde
Fornecendo alta qualidade verificável
Oferecendo cuidados de saúde participativos e personalizados
Usando nossos recursos de forma eficiente
Participar de redes profissionais sustentáveis em todas as áreas
O departamento de oftalmologia do Radboudumc é um importante centro terciário para várias doenças oculares e é um dos principais especialistas no tratamento e tratamento de doenças da retina. Além do atendimento clínico diário, pesquisamos doenças da retina. Os principais objetivos da nossa investigação são compreender melhor a base molecular destas doenças e desenvolver novos dispositivos de diagnóstico e terapias.
O departamento de Genética Humana do Radboudumc realiza pesquisas inovadoras sobre a relação entre genes e doenças. O atendimento ao paciente (divisão de genética clínica) e o diagnóstico genético (divisão de diagnóstico do genoma) realizados no departamento de Genética Humana são hospedados por um Centro oficial e aclamado de Genética Clínica.
Foto: .Koen
Contato
Radboud university medical center, Nijmegen, Netherlands
A Nossa Equipa
Pr Carel HOYNG
Nederland
Pr Frans Cremers
Nederland
Ensaios clínicos
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
A Double-Masked, Randomized, Controlled, Multiple-Dose Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene (Sirius)
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)
Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).
A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).
Safety and Efficacy of Emixustat in Stargardt Disease.
Natural History of the Progression of Choroideremia Study NSR-CHM-OS1.
Rate of Progression in USH2A Related Retinal Degeneration
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher
Natural history of the progression of X-linked retinitis pigmentosa.